Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Birth Control Methods01:22

Birth Control Methods

Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Oral Drug Delivery Systems: Continuous-Release Systems01:26

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for poor oocyte yield and oocyte immaturity after GnRH agonist triggering.

Human reproduction (Oxford, England)·2024
Same author

[Becoming requesting couples after their registration in oocyte donation].

Gynecologie, obstetrique, fertilite & senologie·2022
Same author

Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.

Maturitas·2022
Same author

[Evaluation of the success of medical abortion by a plasma hCG control threshold].

Gynecologie, obstetrique, fertilite & senologie·2021
Same author

[Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines (Short version)].

Gynecologie, obstetrique, fertilite & senologie·2021
Same author

[Benefit-risk balance of hormone replacement therapy: Cancers and mortality. Postmenopausal women management - CNGOF and GEMVi clinical practice guidelines].

Gynecologie, obstetrique, fertilite & senologie·2021
Same journal

[How I do… to see the sliding sign by transvaginal ultrasonography?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Cell-free fetal DNA screening tests for trisomy 21].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Lucy's cancer(s): A prehistorical origin?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Male age in assisted reproductive technologies: Is there a limit?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Iodinated contrast in pregnant women and neonatal thyroid function].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Breast cancer and diabetes mellitus: Complex interactions].

Gynecologie, obstetrique & fertilite·2016
See all related articles

Related Experiment Videos

[Postpartum birth control: state-of-the-art].

G Robin1, P Massart, F Graizeau

  • 1Service de gynécologie-obstétrique, centre hospitalier d'Armentières, rue Sadi-Carnot, 59280 Armentières, France. geoffroy.robin@laposte.net

Gynecologie, Obstetrique & Fertilite
|June 14, 2008
PubMed
Summary
This summary is machine-generated.

Postpartum contraception is crucial as ovulation can occur soon after delivery. Healthcare providers should offer updated contraceptive information and options before patients leave the maternity ward to prevent unintended pregnancies.

Related Experiment Videos

Area of Science:

  • Obstetrics and Gynecology
  • Reproductive Health
  • Family Planning

Context:

  • Menstrual flow typically resumes six weeks postpartum, but ovulation can occur as early as 25 days after delivery.
  • Postpartum contraception is essential and requires proactive management in maternity wards.
  • Healthcare providers must offer updated information on various contraceptive methods.

Purpose:

  • To review and update medical practices regarding postpartum contraception.
  • To emphasize the importance of diagnosing risk factors and prescribing suitable contraceptive options before hospital discharge.
  • To simplify the contraceptive prescription process and reduce unwanted pregnancies.

Summary:

  • Combined oral contraceptives with low dosages are safe for women without additional risk factors, posing no increased risk of deep venous thrombosis or significant breastfeeding disruption.
  • Low-dose progestin-only pills are a safe option during lactation.
  • Intrauterine devices (IUDs) can be inserted 4-6 weeks postpartum, or even immediately after delivery in certain cases, including during cesarean sections.

Impact:

  • Facilitates informed decision-making for postpartum women regarding contraception.
  • Empowers healthcare providers to offer timely and effective contraceptive solutions.
  • Aims to decrease the incidence of unintended pregnancies in the postpartum period.